• Opinion
• [Reporter's view] Two plays in the parliamentary audit
• by Kim, Jin-Gu Oct 25, 2022 05:46am

• Company
• Genuone challenges Trajenta’s non-listed patent...Why?
• by Kim, Jin-Gu Oct 25, 2022 05:46am

• Company
• Cibinqo lands in general hospitals in Korea
• by Eo, Yun-Ho Oct 25, 2022 05:46am

• Company
• GSK has signed a sales contract with GC Pharma & Kwang Dong
• by Eo, Yun-Ho Oct 25, 2022 05:46am

• Policy
• Lenvima's PMS results for 6 years
• by Lee, Hye-Kyung Oct 25, 2022 05:45am

• Company
• Lyumjev can be prescribed in general hospitals
• by Eo, Yun-Ho Oct 24, 2022 06:08am

• Company
• Will Onureg, an acute leukemia maintenance drug be listed?
• by Eo, Yun-Ho Oct 24, 2022 06:08am

• Policy
• How did Zerbaxa get recognized for its benefit?
• by Lee, Tak-Sun Oct 24, 2022 06:08am

• Policy
• Will Gilead reclaim its throne in the HCV drug market?
• by Lee, Tak-Sun Oct 24, 2022 06:08am

• Company
• Lucentis biosimilar of Chong Kun Dang gets domestic approval
• by Chon, Seung-Hyun Oct 24, 2022 06:08am